 MOORESTOWN, N.J., Aug. 25, 2021 PRNewswire -- Tabula Rasa HealthCare, Inc. TRHC NASDAQ: TRHC, a leading healthcare technology company advancing the safe use of medications, and Hesperos Inc., pioneers of Human-on-a-Chip in vitro systems, have been awarded 1.9 million in funding from the National Institutes of Health NIH to investigate drug-induced dementia and develop new models that will drive Alzheimers research. 